SAN FRANCISCO The American Association for Cancer Research will host its Second AACR International Conference on Frontiers in Basic Cancer Research at the InterContinental San Francisco Hotel from Sept. 14-18, 2011.
This conference is an opportunity for the world's leading scientists to share ideas and breakthroughs that will expedite the development of lifesaving cancer therapeutics from the lab to the clinic.
"We are truly in an exciting period for cancer research, as work that started by addressing basic questions about cancer is coming to clinical fruition. The more we can collaborate and reach synergy through conferences like this, the closer we will come to lifesaving treatments," said conference chairperson Elizabeth H. Blackburn, Ph.D., the Morris Herzstein professor of biology and physiology in the department of biochemistry and biophysics at the University of California, San Francisco.
Blackburn, immediate past president of the AACR, won the 2009 Nobel Prize in Physiology or Medicine for her role in the discovery of telomerase.
On Thursday, Sept. 15, 2011, at 10:00 a.m. PT, conference co-chairperson Ren Bernards, Ph.D., professor of molecular carcinogenesis at The Netherlands Cancer Institute in Amsterdam, will host a press conference on the following research.
The following information is embargoed until 10:00 a.m. PT on Thursday, Sept. 15.
Reporters who cannot attend in person can participate by using the following information:
|Contact: Jeremy Moore|
American Association for Cancer Research